Noble Medicals Private Limited - Due diligence report

A 360° intelligence report on Noble Medicals: trust score, financial health, credit view, compliance, directors, growth and distress signals…

2013-05-28 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
NM Noble Medicals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Noble Medicals — 360° Intelligence Report

Generated from MCA filings & public records
94/100
Trust Score
Low Risk

Noble Medicals is assessed as Low Risk with a Trust Score of 94/100. Noble Medicals is an active private limited indian non-government company incorporated in 2013, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 18 Aug 2026 from the latest processed filings. Noble Medicals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MIHIR BAKUL KAPADIA 01234567 Director 01/04/2018 6 yrs Approved
ANUJ DHARMANATH PANDEY 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
-

Promoters hold a minority stake - exact percentages are part of the full report.

Group entityRelationship% held
Noble Medichem Private Limited Associate Company 74.00%

Key managerial personnel: MIHIR BAKUL KAPADIA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Operating for 13+ years.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
15 Feb 2021
Director appointed
ANUJ DHARMANATH PANDEY (Director)
Director ceased
RIMA MIHIR KAPADIA
Director ceased
RAMESH SHANTILAL MEHTA
28 May 2013
Incorporated
Registered with Roc Mumbai I
Director appointed
MIHIR BAKUL KAPADIA (Managing Director)
10

Key Observations

Auto-generated from the data above
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a minority stake as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Pin Peripheral Private Limited U74999MH2019PTC322576 Grant Rd,Giragaon,Mumbai, Maharashtra, India
Wee Bros Techno-Mech Private Limited U25200MH1988PTC046391 Mumbai, Maharashtra, India
Apsara Enterprises Private Limited U70109UP2018PTC103878 Aligarh, Uttar Pradesh, India
Researchco International Private Limited U74140DL2012PTC244640 Delhi, Delhi, India
Cityfurnish U36100RJ2015PTC048304 Jodhpur, Rajasthan, India
Ajay Auto Limited U34101DL1986PLC026334 New Delhi, Delhi, India
Atmosphere Impex Private Limited U41000DL2008PTC173192 New Delhi, Delhi, India
Abhiyan Merchants Pvt Ltd U51109WB1996PTC078458 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Noble Medicals before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Noble Medicals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Noble Medicals - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Noble Medicals pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Noble Medicals - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Noble Medicals an active company?

Noble Medicals has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Noble Medicals financially healthy?

Noble Medicals has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Noble Medicals?

Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Noble Medicals?

Promoters hold a minority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Noble Medicals have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Noble Medicals up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Noble Medicals?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.